NO20016099L - Optisk aktive pyrrolopyridazinforbindelser - Google Patents

Optisk aktive pyrrolopyridazinforbindelser

Info

Publication number
NO20016099L
NO20016099L NO20016099A NO20016099A NO20016099L NO 20016099 L NO20016099 L NO 20016099L NO 20016099 A NO20016099 A NO 20016099A NO 20016099 A NO20016099 A NO 20016099A NO 20016099 L NO20016099 L NO 20016099L
Authority
NO
Norway
Prior art keywords
optically active
compounds
activity against
active pyrrolopyridazine
alkyl
Prior art date
Application number
NO20016099A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016099D0 (no
Inventor
Masahiko Hagihara
Nobuhiko Shibakawa
Keiji Matsunobu
Hiroshi Fujiwara
Keiichi Ito
Original Assignee
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries filed Critical Ube Industries
Publication of NO20016099D0 publication Critical patent/NO20016099D0/no
Publication of NO20016099L publication Critical patent/NO20016099L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20016099A 1999-06-15 2001-12-14 Optisk aktive pyrrolopyridazinforbindelser NO20016099L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16767999 1999-06-15
PCT/JP2000/003895 WO2000077003A1 (fr) 1999-06-15 2000-06-15 Composes de pyrrolopyridazine optiquement actifs

Publications (2)

Publication Number Publication Date
NO20016099D0 NO20016099D0 (no) 2001-12-14
NO20016099L true NO20016099L (no) 2002-02-07

Family

ID=15854223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016099A NO20016099L (no) 1999-06-15 2001-12-14 Optisk aktive pyrrolopyridazinforbindelser

Country Status (25)

Country Link
US (1) US6670360B2 (cs)
EP (1) EP1186607B1 (cs)
KR (1) KR100583663B1 (cs)
CN (1) CN1170829C (cs)
AT (1) ATE240957T1 (cs)
AU (1) AU757611B2 (cs)
BR (1) BR0011666A (cs)
CA (1) CA2375848A1 (cs)
CZ (1) CZ290935B6 (cs)
DE (1) DE60002860T2 (cs)
DK (1) DK1186607T3 (cs)
ES (1) ES2198319T3 (cs)
HK (1) HK1044341B (cs)
HU (1) HUP0201434A3 (cs)
IL (2) IL147088A0 (cs)
MX (1) MXPA01013011A (cs)
NO (1) NO20016099L (cs)
NZ (1) NZ516194A (cs)
PL (1) PL356479A1 (cs)
PT (1) PT1186607E (cs)
RU (1) RU2222541C2 (cs)
TR (1) TR200103685T2 (cs)
TW (1) TWI287014B (cs)
WO (1) WO2000077003A1 (cs)
ZA (1) ZA200110279B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1049163B (en) 2000-02-10 2007-09-28 Sankyo Company, Limited Pyrrolopyridazine compound
TW200420293A (en) * 2002-09-25 2004-10-16 Sankyo Co Pharmaceutical compositions for the reduction of gastric acid concentration in blood
AU2003266621A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for treatment for or prevention of visceral pain
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
CN101010321B (zh) * 2004-09-03 2011-10-26 株式会社柳韩洋行 吡咯并[3,2-b]吡啶衍生物及其制备方法
CN101003537A (zh) * 2006-01-17 2007-07-25 上海恒瑞医药有限公司 吡咯并哒嗪类衍生物及其制备方法和用途
KR101605063B1 (ko) 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97931A0 (en) 1990-04-27 1992-06-21 Byk Gulden Lomberg Chem Fab Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
WO1992006979A1 (de) 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
AU2870492A (en) 1991-10-25 1993-05-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrrolo-pyridazines with gastro-intestinal protective action
ES2185693T3 (es) * 1994-01-19 2003-05-01 Sankyo Co Derivado de pirrolopiridacina.

Also Published As

Publication number Publication date
MXPA01013011A (es) 2002-11-07
IL147088A (en) 2006-12-31
NZ516194A (en) 2003-03-28
AU5426900A (en) 2001-01-02
TR200103685T2 (tr) 2002-05-21
AU757611B2 (en) 2003-02-27
NO20016099D0 (no) 2001-12-14
CZ290935B6 (cs) 2002-11-13
ES2198319T3 (es) 2004-02-01
US6670360B2 (en) 2003-12-30
EP1186607A1 (en) 2002-03-13
DK1186607T3 (da) 2003-09-01
BR0011666A (pt) 2002-03-19
CZ20014505A3 (cs) 2002-05-15
DE60002860T2 (de) 2004-05-06
PT1186607E (pt) 2003-08-29
HUP0201434A2 (en) 2002-08-28
HK1044341B (en) 2003-10-03
CA2375848A1 (en) 2000-12-21
HK1044341A1 (en) 2002-10-18
IL147088A0 (en) 2002-08-14
EP1186607B1 (en) 2003-05-21
ATE240957T1 (de) 2003-06-15
TWI287014B (en) 2007-09-21
DE60002860D1 (de) 2003-06-26
US20020156079A1 (en) 2002-10-24
WO2000077003A1 (fr) 2000-12-21
CN1370172A (zh) 2002-09-18
EP1186607A4 (en) 2002-07-03
KR100583663B1 (ko) 2006-05-26
HUP0201434A3 (en) 2003-09-29
PL356479A1 (en) 2004-06-28
RU2222541C2 (ru) 2004-01-27
CN1170829C (zh) 2004-10-13
KR20020022703A (ko) 2002-03-27
ZA200110279B (en) 2003-05-28

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EP1535915A4 (en) FURANOIC OR THIOPHENE DERIVATIVES AND THEIR MEDICAL USE
CA2338311A1 (en) Prodrugs of the pyridyl methyl sulfinyl benzimidazoles
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
AU2804400A (en) Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
DE60115465D1 (de) Immunoregulierende verbindungen, deren derivate und ihre verwendung
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
EP1396493A4 (en) HETEROCYCLIC COMPOUNDS
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
NO20014925L (no) Farmasöytiske forbindelser
NO20051263L (no) Ny anvendelse av benzotiazolderivater
WO2002008219A3 (en) 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
ATE188702T1 (de) Thienodiazepinverbindungen und ihre verwendung
NO20016099L (no) Optisk aktive pyrrolopyridazinforbindelser
WO2003007954A3 (en) Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
HUP0201284A2 (hu) Hatóanyagként kinazolindionszármazék kimáz inhibitort tartalmazó gyógyászati készítmények fibrózis megelőzésére vagy kezelésére
DK0585722T3 (da) Benzimidazolderivater som antimikrobielt middel mod Campylobacter pylon
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
DE60127535D1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation
HUP0201282A2 (hu) Hatóanyagként kinazolindionszármazék kimázinhibitort tartalmazó gyógyászati készítmények dermatitisz megelőzésére és kezelésére
NO972731L (no) Thiazolidinonforbindelser og terapeutisk eller forhindrende middel mot angina pectoris omfattende forbindelsene som aktiv bestanddel
MXPA04000485A (es) Uso de acidos aril o heteroaril hidroxamicos de sulfonilo y derivados de los mismos como inhibidores de agrecanasa.
NO20013601L (no) Nye morfolinobenzamidsalter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application